CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-08 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Grant or award | +8,811 | $0.00 | $9 | 92,362 |
| 2020-03-08 | MOY JEFFREY EVP Operations | Grant or award | +8,811 | $0.00 | $9 | 39,219 |
| 2020-03-08 | Abbey Donald EVP Quality and Regulatory Aff | Grant or award | +8,811 | $0.00 | $9 | 77,757 |
| 2020-03-08 | Murphy Patrick Michael * | Grant or award | +8,811 | $0.00 | $9 | 35,258 |
| 2020-03-05 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Exercise or conversion | +8,927 | $9.80 | $87K | 83,551 |
| 2020-03-05 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Exercise or conversion · Incentive Stock Option (right to buy) | −8,927 | 0 | ||
| 2020-03-03 | FOLETTA MARK G Director | Sale | −107 | $270.63 | $29K | 14,040 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −152 | $271.54 | $41K | 13,888 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −81 | $272.82 | $22K | 13,807 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −155 | $274.88 | $43K | 13,652 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −114 | $275.56 | $31K | 13,538 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −64 | $277.48 | $18K | 13,474 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −31 | $279.60 | $9K | 13,443 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −53 | $281.61 | $15K | 13,390 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −84 | $282.77 | $24K | 13,306 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −75 | $285.48 | $21K | 13,231 |
| 2020-03-03 | FOLETTA MARK G Director | Sale | −84 | $288.26 | $24K | 13,147 |
| 2020-03-02 | MOY JEFFREY EVP Operations | Sale | −362 | $278.10 | $101K | 25,032 |
| 2020-02-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −467 | $275.99 | $129K | 11,779 |
| 2020-02-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −852 | $278.03 | $237K | 10,927 |
Page 63 of 72 · 1,429 trades